红紫罗兰
估值 各估值倍数与自身5年区间的对比
同业对比 Software - Application
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| 红紫罗兰 (RDVT) | 1.19B | 64.91 | 10.64 | 0.00% |
| SAP SE (SAP) | 258.88B | 29.92 | 5.16 | 1.28% |
| Shopify (SHOP) | 218.11B | 114.54 | 17.20 | 0.00% |
| Salesforce (CRM) | 198.10B | 22.04 | 5.16 | 0.71% |
| ServiceNow (NOW) | 146.78B | 88.73 | 11.73 | 0.00% |
| Uber Technologies (UBER) | 143.69B | 15.43 | 5.26 | 0.00% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价高于晨星合理价值估算3.9%。
合理价值
Red Violet Inc earns a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 10% premium over our quantitative fair value estimate of $71.14 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.
The firm's valuation metrics weaken our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 10.0% ranks in the bottom 10% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.
The firm's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 2.0%, for example, sits in the bottom 40% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.
经济护城河
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
作者:Quantitative Equity Report
报价时间 2026-10-16 20:02:30 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
红紫罗兰 讨论区 0 条评论